We want to start with the basics about Hormone Replacement Therapy, so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what Hormone…
Read More ➝
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…
Read More ➝
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
We had an excellent question from a participant who has the KRAS-variant and had chosen to have her ovaries removed. She asked her OB/GYN if she still needed to have pelvic exams…
Read More ➝
Webinar – KRAS-Variant and Breast Cancer Did you miss our live webinar on the KRAS-Variant with Dr. Joanne Weidhaas? Watch the replay and learn about how this genetic mutation can impact your…
Read More ➝
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
Post Updated February 7, 2022 For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN. So what can we…
Read More ➝
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation that predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. We all know something about menopause, but just like pregnancy or bungee jumping, you…
Read More ➝
Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…
Read More ➝
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
